FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing to remove from the market a common ingredient found in most oral over-the ...
Business Insider5d
IO Biotech reports data on IO102-IO103 vaccine in combination with KEYTRUDA
IO Biotech (IOBT) announced data from the NSCLC cohort in the company’s Phase 2 basket trial of IO102-IO103, the company’s lead investigational candidate, given in combination with Merck’s anti-PD-1 ...
Business Insider15d
Merck, Moderna launch Phase 3 trial evaluating adjuvant V940, Keytruda combo
in combination with Keytruda, Merck’s anti-PD-1 therapy, as adjuvant treatment for patients with resectable Stage II, IIIA or IIIB non-small cell lung cancer who did not achieve a pathological ...
Cure Today15d
Phase 3 Trial Begins in mRNA-Based Therapy Plus Keytruda in Non-Small Cell Lung Cancer
The INTerpath-009 trial will investigate an individualized neoantigen therapy plus Keytruda in patients with non-small cell lung cancer post-surgery whose disease didn't fully respond to prior ...
precisionmedicineonline15d
Merck, Moderna Launch Phase III Trial of Adjuvant V940 in NSCLC After Neoadjuvant Keytruda, Chemo
NEW YORK – Moderna and Merck will test their personalized neoantigen cancer vaccine V940 with Merck's checkpoint inhibitor Keytruda (pembrolizumab) in certain non-small cell lung cancer patients in a ...
Yahoo Finance19d
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers
KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless of ...
Nasdaq19d
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers
KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...
BioSpace19d
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers
In general, if KEYTRUDA requires interruption or discontinuation, administer systemic corticosteroid therapy (1 to 2 mg/kg/day prednisone or equivalent) until improvement to Grade 1 or less. Upon ...
Autocar India25d
MG ES5 electric SUV revealed
It has a top speed of 170kph and does 0-100 in 8 seconds. MG Motor will introduce this SUV overseas with three different battery sizes. While more details on the battery capacity are not out yet ...
RushLane25d
2025 MG ES5 EV Exteriors, Interiors, Colours Revealed – New TVC Out
The new interior takes a minimalist approach and has an Ivory theme for upholstery and a dual-tone theme for dashboard and door panels MG Motor has just taken the veil off its new ES5 EV.
Carscoops26d
MG ES5 Electric SUV Breaks Cover, Replaces ZS EV
MG published the first photos of the ES5, a fully electric SUV for global markets. The ES5 will replace the MG ZS EV, with a larger footprint and modern technology. The MG4-based SUV is powered by ...